A multiphasic contraceptive regimen for an oral formulation of progestin and estrogen
WO2012138542A1
Treatment of menstrual pain and excessive menstrual blood loss by intravaginal administration of a low dose of antifibrinolytic or hemostatic agent in combination with non- steroidal anti-inflammatory drug
WO2012121811A1
Treatment of excessive menstrual blood loss by intravaginal administration of low doses of antifibronlytic or hemostatic agent
WO2012121778A1
Treatment of endometriosis by intravaginal administration of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent
WO2012121767A1
Treatment of uterine fibroids by intravaginal administration of a low dose of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent
WO2012118541A1
Treatment of excessive menstrual blood loss by feminine sanitary products medicated with antifibrinolytic or hemostatic agent
WO2012141741A1
Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood loss
